Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Serum albumin-fused interleukin-10 prevents neuroinflammation by promoting immunoregulation in the secondary lymphoid organs and limiting immune cell infiltration in the spinal cord.
Journal: bioRxiv : the preprint server for biology
Published: April 27, 2026
Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic airway disease in mice.
Journal: Science translational medicine
Published: April 16, 2025
Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis.
Journal: Cell reports. Medicine
Published: May 03, 2024
LDL-Binding IL-10 Reduces Vascular Inflammation in Atherosclerotic Mice.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024
LDL-binding IL-10 reduces vascular inflammation in atherosclerotic mice.
Journal: Nature biomedical engineering
Published: February 29, 2024
Author Correction: Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds.
Journal: NPJ Regenerative medicine
Published: November 03, 2023
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice.
Journal: Nature biomedical engineering
Published: May 17, 2023
Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds.
Journal: NPJ Regenerative medicine
Published: November 09, 2022
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Journal: Nature biomedical engineering
Published: August 23, 2022
Last Updated: 09/26/2026